Skip to main content

Table 2 Number of virus-positive patients and virus distribution between treatment groups*

From: Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial

 

n VP patients*

RSV

Corona 229E

Corona OC43

hMPV

hRV

Influenza A

PIV3

ITT

118/203

4

32

21

5

60

13

1

V

59/102

3

16

13

2

27

7

0

P

59/101

1

16

8

3

33

6

1

  1. *Some patients had more than one virus.
  2. hMPV = Human metapneumovirus; hRV = Human rhinovirus; ITT = Intention to treat population; P = Placebo; PIV3 = Parainfluenza virus type 3; V = Carrageenan; VP = Virus-positive patients.